Adult structural heart disease is often missed. Early detection and continuous monitoring are vital. Modern treatments like ...

Article by By Sara Farkash: "I am not someone who goes to doctors. I’m the opposite. I avoid it unless absolutely necessary.

Acarix CEO Aamir Mahmood moved his medical tech company to Oklahoma City to improve heart health with a novel diagnostic tool.

Elucid announced today the commercial availability of a new Lesion Inspection Tool for coronary and carotid plaque analysis in its novel Plaque-IQ software suite. The tool provide ...

Morgans healthcare analyst Iain Wilkie highlights seven ASX companies with upcoming catalysts in 2026. ... Read More The post ...

The Society for Cardiovascular Angiography & Interventions (SCAI) today announced that Alexandra J. Lansky, MD, MSCAI, has ...

Every year, around 46,000 people in the UK experience a transient ischaemic attack TIA, or ‘mini stroke’, for the first time. Causing similar symptoms to a full stroke, the difference is that TIAs ...

What happens when this doctor goes keto and his LDL rockets to 574? We dive deep into the science, controversy, and personal ...

Cardiology experts from UCSF Health presented new research and clinical findings at the American College of Cardiology’s (ACC) Annual Scientific Session and Expo in New Orleans, March 28 to 30. The ...

CTAHN leads to acute management changes in a minority of patients, with the highest diagnostic yield found in stroke and headache cases.

Assessing intermediate coronary lesions with an intracoronary pressure wire improves clinical outcomes in patients undergoing cardiac catheterization and percutaneous coronary intervention (PCI).